Leef BrandsLEEEF -3.00%30 Altman Z-Score is -4.12 as of Jun. 24, 2026. GuruFocus rates LEEEF with a GF Score™ of 30/100 and a GF Value™ of $0.13 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 952 Drug Manufacturers companies, Leef Brands ranks worse than 92.44% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Warning Sign:
Altman Z-score of -4.09 is in distress zone. This implies bankruptcy possibility in the next two years.
Leef Brands has a Altman Z-Score of -4.12, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Leef Brands's Altman Z-Score or its related term are showing as below:
LEEEF'
s Altman Z-Score Range Over the Past 10 Years
Min: -8879.72 Med: -1.26 Max: 287.48
Current: -4.09
During the past 13 years, Leef Brands's highest Altman Z-Score was 287.48. The lowest was -8879.72. And the median was -1.26.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Leef Brands Altman Z-Score Related Terms
Leef Brands Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Leef Brands's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Leef Brands's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leef Brands Altman Z-Score vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Leef Brands's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Leef Brands's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Leef Brands's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.1407
+
1.4
*
-3.3406
+
3.3
*
-0.3216
+
0.6
*
1.0289
+
1.0
*
0.8307
=
-4.12
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Leef Brands (LEEEF) has a Altman Z-Score of -4.12 as of Jun. 24, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Leef Brands and its competitors. According to the industry distribution chart, Leef Brands ranks #880 out of 952 companies in the Drug Manufacturers industry, placing it in the top 92.4%.
Is Leef Brands' Altman Z-Score too high?
Leef Brands' current Altman Z-Score is -4.12. Based on the distribution chart, Leef Brands ranks #880 out of 952 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Leef Brands has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Leef Brands' Altman Z-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Leef Brands ranks #880 out of 952 companies for Altman Z-Score. This places Leef Brands in the lower half of its industry. The industry median Altman Z-Score is 3.32. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Drug Manufacturers company?
The median Altman Z-Score among Drug Manufacturers companies is 3.32, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Leef Brands and its competitors. For the Drug Manufacturers industry, the median Altman Z-Score is 3.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leef Brands's current Altman Z-Score is -4.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leef Brands stock overvalued right now?
Based on GuruFocus' analysis, Leef Brands (LEEEF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.13, compared to a current price of $0.17 — trading 33.3% above its estimated fair value. The current Altman Z-Score is -4.12. Leef Brands' overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Leef Brands (LEEEF), the current Altman Z-Score is -4.12 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Leef Brands (LEEEF) Overvalued in 2026?
Based on GuruFocus' analysis, Leef Brands stock appears to be overvalued.
The current stock price of $0.17 is trading 33.3% above its estimated GF Value™ of $0.13.
GuruFocus considers Leef Brands to be Significantly Overvalued.
Key valuation signals for LEEEF:
Altman Z-Score: -4.12
GF Value™: $0.13 vs. price of $0.17 (33.3% above fair value)
No single metric tells the full story. See the LEEEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Leef Brands Inc is a vertically integrated cannabis extraction and manufacturing operator based in California. The company operates in two reportable segments: Wholesale concentrates and Retail. The wholesale concentrate segment includes the propagation, nursery, flowering canopy, drying, processing, manufacturing and distribution of cannabis concentrates. The retail segment includes company owned and operated retail cannabis store in the state of California. It derives majority of the revenue from Wholesale concentrates segment.
30GF Score
Get the complete analysis for LEEEF
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LEEEF has been successfully added to your 
